Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 18/20 | 0.65 |
| ▸ | HTR2C | P28335 | 11/20 | 0.65 |
| ▸ | HTR2B | P41595 | 11/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26080781 | 0.83 | HTR2A (0.44) | HTR2AHTR2CHTR2B | |
| SCHEMBL25358431 | 0.79 | HTR2A (1.00) | HTR2AHTR2CHTR2B | |
| SCHEMBL26080790 | 0.78 | HTR2A (0.51) | HTR2AHTR2CHTR2B | |
| Hydrochloric Acid SCHEMBL31722770 | 0.78 | HTR2A (1.00) | HTR2AHTR2CHTR2B | |
| SCHEMBL25373035 | 0.77 | HTR2A (1.00) | HTR2AHTR2CHTR2B | |
| SCHEMBL13807507 | 0.68 | HTR2A (0.54) | HTR2AHTR2CHTR2B | |
| SCHEMBL26011956 | 0.68 | HTR2A (0.77) | HTR2AHTR2CHTR2B | |
| SCHEMBL25362206 | 0.67 | HTR2A (1.00) | HTR2AHTR2CHTR2B | |
| SCHEMBL26014131 | 0.66 | HTR2A (0.66) | HTR2AHTR2CHTR2B | |
| SCHEMBL25693440 | 0.66 | HTR2A (0.56) | HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312464-A1 | THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE | CYBIN IRL LIMITED (IE) | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312464-A1 | THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE | HTR2C, HTR5A, HTR2A | HTR2A 3/4885HTR2C 1/4885HTR2B 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.